Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter

TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake Watch Now

TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential


Glaxosmithkline Share Chat (GSK)



Share Price: 1,584.40Bid: 1,587.00Ask: 1,587.20Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.20Spread as %: 0.01%Open: 1,567.00High: 0.00Low: 0.00Yesterday’s Close: 1,584.40


Share Discussion for Glaxosmithkline


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

Pokerchips
Posts: 7,495
Opinion:No Opinion
Price:1,451.60
RE: Round trip ...
11 Oct '18
Mike

If you want 6% you can be sure there will be a queue alongside you...LOL

Think plenty will settle for 5% or 5.5% and as such 1333p is a lot to ask for

Any measures you seen that point you to 1333p ?
 
Pokerchips
Posts: 7,495
Opinion:No Opinion
Price:1,451.60
RE: Round trip ...
11 Oct '18
Bears gave a clear signal in the last 90 minutes ...

Need to watch NYSE: GSK

Took a similar drop but bouncing off the drop.....really need to watch that ..see where it finishes tonight
MrBeaky
Posts: 1,614
Opinion:No Opinion
Price:1,457.00
RE: Round trip ...
11 Oct '18
Was expecting a green day today with reinvestments but almost down 2%. Market is relentless.
LordAdam
Posts: 630
Opinion:No Opinion
Price:1,483.60
Round trip ...
11 Oct '18
If you sold at 1600 (which I did) then buying at 1404 gives you a 15% profit on the round trip. That compares very favorably with a sit-and-hold strategy of just collecting the (5-6%) dividend.

But my real buying target is actually in the area of 1333 when the yield hits 6%.

Gut tells me that it will get down to that, or close to it, some time over the next 6-12 months.

We shall see ...

Mike
Pokerchips
Posts: 7,495
Opinion:No Opinion
Price:1,485.40
RE: Climb today
9 Oct '18
Dividend pay date 11th October which the div holders may buy shares with...boost on the SP

But then what ?

Next Ex Div 15th November

One to really watch ..along with GLAXO in New York
Pokerchips
Posts: 7,495
Opinion:No Opinion
Price:1,471.20
RE: Climb today
9 Oct '18
Market can love GSK ....but as always...it depends at what price

its in a bear pull back ...

I will love it when I get the right price for it ...which isnt yet

IMO DYOR
IvaP
Posts: 156
Opinion:No Opinion
Price:1,527.80
RE: Climb today
2 Oct '18
Waiting for this to go sub 1500 again before buying again.
Market doesn't seem to like GSK any more.
iknowverylittle
Posts: 471
Opinion:No Opinion
Price:1,520.60
RE: Climb today
21 Sep '18
Sweet, nice rise.
riolto10
Posts: 1,938
Opinion:No Opinion
Price:1,521.80
RE: Climb today
21 Sep '18
Totally agree /Pound drop
MrBeaky
Posts: 1,614
Opinion:No Opinion
Price:1,518.60
RE: Climb today
21 Sep '18
Because of pound dropping like a stone
AvatarIII
Posts: 39
Opinion:No Opinion
Price:1,507.00
Climb today
21 Sep '18
Due to payday/share schemes possibly?
Craigl
Posts: 6,150
Opinion:No Opinion
Price:1,484.20
RE: why the drop?
16 Sep '18
Ha Ha
AllAtSea
Posts: 919
Opinion:No Opinion
Price:1,484.20
RE: why the drop?
16 Sep '18
Ssshhh! Don't tell anyone..
Craigl
Posts: 6,150
Opinion:No Opinion
Price:1,484.20
RE: why the drop?
15 Sep '18
Look at the history of this share it drops to 12 to 13 then goes back up to 16 area . A great predictable share
Pokerchips
Posts: 7,495
Opinion:No Opinion
Price:1,484.20
RE: New AIDS Treatment
15 Sep '18
To be clear...it isnt an AIDS treatment ...it is an HIV treatment which helps prevent the possible onset of AIDS in patients who have been diagnosed HIV+
Inkose
Posts: 41
Opinion:No Opinion
Price:1,484.20
New AIDS Treatment
15 Sep '18
Glaxosmithkline said its ViiV Healthcare joint venture had submitted a marketing authorisation application to the European Medicines Agency for a single-tablet, two-drug regimen for the treatment of HIV. The submission was based on studies that included more than 1400 infected adults, the results of which were presented at the 2018 International AIDS Society meeting in July. A new drug application to the US FDA was planned for the single tablet regimen for October. Other global regulatory submissions of dolutegravir and lamivudine as a single-tablet, two-drug regimen were anticipated in the coming months. At 1:09pm: (LON:GSK) GlaxoSmithKline PLC share price was -9.7p at 1485.9p Story provided by StockMarketWire.com
danielh
Posts: 1,433
Opinion:No Opinion
Price:1,495.60
pokerchips
13 Sep '18
Thanks for your answer, it makes sense. Unfortunately I did buy vod shares at over £2,(so more fool me) but also at below the current sp. sorry that i'm on the wrong share chat.
driftking27
Posts: 1,477
Opinion:Weak Buy
Price:1,500.80
RE: why the drop?
13 Sep '18
With the sale of Horlicks being sold of for a reputed $3.9bn this will pay the dividend

I just saw GS make a shout for GSK stock and price target of 1640p, roughly 10% increase from current price
Pokerchips
Posts: 7,495
Opinion:No Opinion
Price:1,502.40
RE: why the drop?
13 Sep '18
DanielH,

" Afford it" .....well they can both afford it in the sense that they just add some of it to the debts ...but the NAV gradually decreases and the value of the business gets erosed ....unless profit margins and revenues improve ....which they could of course

They wont go bust by paying it....but it cant go on without some kind of change to help payy it out of yearly profit

My concern as always with VOD or GSK is to make sure I buy shares on the lows of the cycle .... i never tend to buy VOD over 200p or GSK over 1600p ...these are sell areas for me.....but each to their own

I like the BOD team at GSK .....but I am out of the shares right now.....just keeping an eye for now
danielh
Posts: 1,433
Opinion:No Opinion
Price:1,500.60
RE: why the drop?
13 Sep '18
Pokerchips, are you worried about the vod divi cover & the glaxo cover. As you say the glaxo divi is covered by free cash flow, but that doesn't mean it can definitely afford it, does it?
Pokerchips
Posts: 7,495
Opinion:No Opinion
Price:1,486.00
RE: why the drop?
11 Sep '18
Pokerchips
Posts: 7,495
Opinion:No Opinion
Price:1,487.60
RE: why the drop?
11 Sep '18
you also have to bear in mind that the Div cover here is a measly 0.59 ....with annual dividend payments costing over twice the annual final profit figure

so...whilst the DIV % seems nice ...it is a share that you have to be very careful what you pay for it .....such that...the DIVE cover is wafer thin .....

of course the div is covered by free cash flow ..but....as i said...it costs twice as much a year to pay as the annual profit ....so..the retaining profit is negative ..and debts increased ...

Maybe they will sell Horlicks to pay the dividend this year .......not so sure that is a good way to run the business

A good company ..but... it has to grow profits in order to more securely pay that 3.9 billion pound dividend every year
Pokerchips
Posts: 7,495
Opinion:No Opinion
Price:1,497.80
RE: why the drop?
11 Sep '18
" Dollar vunerable due to Trump"

Donnie Dump is causing the dollar strength IMO ....tariffs, tax cuts etc are driving the dollar higher ...which in turn is causing money in developing countries to flow back to the Dollar .... Treasury yields are also rising further driving up the Dollar ....
Raybab
Posts: 92
Opinion:No Opinion
Price:1,497.20
RE: why the drop?
11 Sep '18
The £ is up agains the $.GSK profits are in $. They need more $ to buy £ to pay DIV.

Doller vunerable due to Trump

Just my view
Stocktaker01
Posts: 1,382
Opinion:No Opinion
Price:1,495.20
why the drop?
11 Sep '18
opinions?




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk









Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.